This research was funded by Youth Project of Sichuan Natural
Science Foundation (No. 2023NSFSC1892).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2024]版：
无
最新[2023]版：
大类|3 区医学
小类|3 区外科
第一作者：
第一作者机构：[1]Lung Cancer Center & Institute, West China Hospital of Sichuan University, Chengdu, 610041, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Zhenkun,Li Pengfei,Wu Qiang,et al.Response to savolitinib in a patient with lung adenocarcinoma harboring a novel MET exon 14 skipping mutation[J].Asian Journal Of Surgery.2024,doi:10.1016/j.asjsur.2023.12.167.
APA：
Liu Zhenkun,Li Pengfei,Wu Qiang&Zhou Qinghua.(2024).Response to savolitinib in a patient with lung adenocarcinoma harboring a novel MET exon 14 skipping mutation.Asian Journal Of Surgery,,
MLA：
Liu Zhenkun,et al."Response to savolitinib in a patient with lung adenocarcinoma harboring a novel MET exon 14 skipping mutation".Asian Journal Of Surgery .(2024)
